KeyBanc Raises Absci Price Target to $20 From $16
KeyBanc maintained its Overweight rating on Absci. The firm said HCIT valuations had mostly recovered from the prior quarter and expects mostly good Q3 results and guidance increases, while noting elevated expectations.